GlassScriptPhysician profile
Jeffrey L Berman
NPI 1407852528
$1,569.48
in general payments reported to CMS, 2019-2025
2 companies · none reported in 2025
See the full distribution for Pediatric Ophthalmology and Strabismus Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $208 · 2021: $418 · 2022: $665.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Retina LLC | $1,560.35 | 2019-2022 | |
| Travere Therapeutics, INC. | $9.13 | 2019-2020 |
Research and ownership
$32,631.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.